Latest

Brain injuries

Breakthrough in Brain Injury Research: Perampanel Shows Significant Advantage in Preventing Acute Symptomatic Seizures

Researchers from Osaka Medical and Pharmaceutical University have published a study in Frontiers in Neurology comparing the effectiveness of perampanel and levetiracetam in preventing acute symptomatic seizures (ASS) following moderate to severe traumatic brain injury (TBI). The study found that perampanel demonstrated a significant advantage over levetiracetam in preventing ASS,

Antiretroviral agents

HIV/AIDS Management and Prevention: A New Frontier in Cardiovascular Disease Management

Current study results indicate that HIV/AIDS patients are disproportionately affected by cardiovascular diseases (CVDs) despite effective viral load suppression with antiretroviral therapy (ART). The mechanisms underlying this relationship are complex and incompletely understood, involving a interplay of traditional cardiovascular risk factors, chronic inflammation, and metabolic side effects of ART.